Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis

Overview of attention for article published in Digestive Diseases and Sciences, March 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 2,628 followers.

RT @joaprimo: Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis #AIH https://t…

https://t.co/NmGOENf6VJ Tacrolimus and MMF in pediatric auoimmune hepatitis. #AIH @AIH_Association @AIHorgUK @autoinmuneinfan

RT @joaprimo: Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis #AIH https://t…

RT @joaprimo: Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis #AIH https://t…

Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis #AIH https://t.co/EgjtHaFMs9